22-38989518-C-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_004900.5(APOBEC3B):​c.631C>T​(p.Arg211Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000378 in 1,588,646 control chromosomes in the GnomAD database, including 52 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.00036 ( 5 hom., cov: 30)
Exomes 𝑓: 0.00038 ( 47 hom. )

Consequence

APOBEC3B
NM_004900.5 missense

Scores

3
16

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: -1.21
Variant links:
Genes affected
APOBEC3B (HGNC:17352): (apolipoprotein B mRNA editing enzyme catalytic subunit 3B) This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. A hybrid gene results from the deletion of approximately 29.5 kb of sequence between this gene, APOBEC3B, and the adjacent gene APOBEC3A. The breakpoints of the deletion are within the two genes, so the deletion allele is predicted to have the promoter and coding region of APOBEC3A, but the 3' UTR of APOBEC3B. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015589505).
BP6
Variant 22-38989518-C-T is Benign according to our data. Variant chr22-38989518-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1048995.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
APOBEC3BNM_004900.5 linkuse as main transcriptc.631C>T p.Arg211Trp missense_variant 5/8 ENST00000333467.4 NP_004891.5 Q9UH17-1
APOBEC3BNM_001270411.2 linkuse as main transcriptc.631C>T p.Arg211Trp missense_variant 5/8 NP_001257340.2 Q9UH17-3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
APOBEC3BENST00000333467.4 linkuse as main transcriptc.631C>T p.Arg211Trp missense_variant 5/81 NM_004900.5 ENSP00000327459.3 Q9UH17-1
APOBEC3BENST00000407298.7 linkuse as main transcriptc.631C>T p.Arg211Trp missense_variant 5/81 ENSP00000385068.3 Q9UH17-3
APOBEC3BENST00000335760.9 linkuse as main transcriptn.570-1814C>T intron_variant 1 ENSP00000338897.5 Q9UH17-2
APOBEC3BENST00000402182.7 linkuse as main transcriptc.631C>T p.Arg211Trp missense_variant 5/72 ENSP00000385060.3 B0QYD3

Frequencies

GnomAD3 genomes
AF:
0.000364
AC:
54
AN:
148486
Hom.:
5
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000980
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000899
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000535
Gnomad OTH
AF:
0.000496
GnomAD3 exomes
AF:
0.000315
AC:
77
AN:
244816
Hom.:
7
AF XY:
0.000279
AC XY:
37
AN XY:
132708
show subpopulations
Gnomad AFR exome
AF:
0.0000617
Gnomad AMR exome
AF:
0.000809
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000100
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000416
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000380
AC:
547
AN:
1440088
Hom.:
47
Cov.:
30
AF XY:
0.000390
AC XY:
279
AN XY:
715916
show subpopulations
Gnomad4 AFR exome
AF:
0.0000600
Gnomad4 AMR exome
AF:
0.000790
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000357
Gnomad4 FIN exome
AF:
0.0000758
Gnomad4 NFE exome
AF:
0.000445
Gnomad4 OTH exome
AF:
0.000254
GnomAD4 genome
AF:
0.000363
AC:
54
AN:
148558
Hom.:
5
Cov.:
30
AF XY:
0.000360
AC XY:
26
AN XY:
72290
show subpopulations
Gnomad4 AFR
AF:
0.0000978
Gnomad4 AMR
AF:
0.000898
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000535
Gnomad4 OTH
AF:
0.000497
Alfa
AF:
0.000383
Hom.:
3
Bravo
AF:
0.000310
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000351
AC:
3
ExAC
AF:
0.000235
AC:
28

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

not provided Benign:1
Likely benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The APOBEC3B p.Arg211Trp variant was not identified in the literature nor was it identified in ClinVar or LOVD 3.0. The variant was identified in dbSNP (ID: rs200770515) and in COSMIC database (FATHMM prediction of neutral; score=0.01). The variant was identified in control databases in 87 of 275244 chromosomes (8 homozygous) at a frequency of 0.000316 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Latino in 29 of 32938 chromosomes (freq: 0.00088), European (non-Finnish) in 53 of 128060 chromosomes (freq: 0.000414), South Asian in 3 of 29926 chromosomes (freq: 0.0001) and African in 2 of 24720 chromosomes (freq: 0.000081); it was not observed in the Ashkenazi Jewish, East Asian, European (Finnish) or Other populations. The variant occurs outside of the splicing consensus sequence and 3 of 4 in silico or computational prediction software programs (MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Arg211 residue is not conserved in mammals or distantly related organisms and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time, although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
14
DANN
Benign
0.97
DEOGEN2
Benign
0.088
.;T;T
Eigen
Benign
-0.95
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.0077
N
LIST_S2
Benign
0.71
T;T;T
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.016
T;T;T
MetaSVM
Benign
-0.75
T
MutationAssessor
Uncertain
2.3
M;.;M
PrimateAI
Benign
0.33
T
PROVEAN
Uncertain
-3.7
D;D;D
REVEL
Benign
0.14
Sift
Benign
0.040
D;D;D
Sift4G
Uncertain
0.021
D;D;D
Polyphen
0.021
.;.;B
Vest4
0.28
MVP
0.65
MPC
0.25
ClinPred
0.055
T
GERP RS
-0.30
Varity_R
0.24
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200770515; hg19: chr22-39385523; COSMIC: COSV59841187; COSMIC: COSV59841187; API